Neon Therapeutics, Inc.
DelistedCIK 1694187fmd_055WJEQCT4SAZRPTFKWHN2R7X7Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2016 to Mar 31, 2020, 14 periods
Latest annual · FY2019
Millions- Operating income
- (81)
- Net income
- (80)
- Free cash flow
- (74)
Latest quarter · Q1 FY2020
Millions- Operating income
- (17)
- Net income
- (17)
- Free cash flow
- (14)
Neon Therapeutics, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2019 | FY2018 | Change | Source |
|---|---|---|---|---|
| Operating income | -$81.1 million | -$78.7 million | 10-K 2020-03-02 · proof | |
| Net income | -$79.8 million | -$76.9 million | 10-K 2020-03-02 · proof | |
| Cash from operating activities | -$73.4 million | -$63.4 million | 10-K 2020-03-02 · proof | |
| Free cash flow | -$74.5 million | -$66.7 million | 10-K 2020-03-02 · proof | |
| Total assets | $46.4 million | $114.1 million | -59.4% | 10-K 2020-03-02 · proof |
| Total liabilities | $17 million | $12.8 million | +32.1% | 10-K 2020-03-02 · proof |
| Cash and cash equivalents | $29.4 million | $52.7 million | -44.2% | 10-K 2020-03-02 · proof |
- What was Neon Therapeutics, Inc.'s operating income in fiscal 2019?
- Neon Therapeutics, Inc. reported operating income of -$81.1 million for fiscal 2019 (the year ended Dec 31, 2019), against -$78.7 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2020. SEC
- What was Neon Therapeutics, Inc.'s net income in fiscal 2019?
- Neon Therapeutics, Inc. reported net income of -$79.8 million for fiscal 2019 (the year ended Dec 31, 2019), against -$76.9 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2020. SEC
- What was Neon Therapeutics, Inc.'s cash from operating activities in fiscal 2019?
- Neon Therapeutics, Inc. reported cash from operating activities of -$73.4 million for fiscal 2019 (the year ended Dec 31, 2019), against -$63.4 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2020. SEC
- What was Neon Therapeutics, Inc.'s free cash flow in fiscal 2019?
- Neon Therapeutics, Inc. reported free cash flow of -$74.5 million for fiscal 2019 (the year ended Dec 31, 2019), against -$66.7 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2020. SEC
- What are Neon Therapeutics, Inc.'s total assets?
- As of Dec 31, 2019, Neon Therapeutics, Inc. reported total assets of $46.4 million, against $114.1 million a year earlier (-59.4%). Source: the 10-K filed with the SEC on Mar 2, 2020. SEC
- What are Neon Therapeutics, Inc.'s total liabilities?
- As of Dec 31, 2019, Neon Therapeutics, Inc. reported total liabilities of $17 million, against $12.8 million a year earlier (+32.1%). Source: the 10-K filed with the SEC on Mar 2, 2020. SEC
- What are Neon Therapeutics, Inc.'s cash and cash equivalents?
- As of Dec 31, 2019, Neon Therapeutics, Inc. reported cash and cash equivalents of $29.4 million, against $52.7 million a year earlier (-44.2%). Source: the 10-K filed with the SEC on Mar 2, 2020. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1694187&period_type=annual&limit=5"Information only, not investment advice.